-
32004R0854R(06)
This corrigendum does not concern the English version.
-
32004R0854R(07)
This corrigendum does not concern the English version.
-
32004R0854R(08)
This corrigendum does not concern the English version.
-
32004R0854R(09)
This corrigendum does not concern the English version.
-
32004R0853R(13)
This corrigendum does not concern the English version.
-
32004R0853R(12)
This corrigendum does not concern the English version.
-
32004R0853R(11)
This corrigendum does not concern the English version.
-
32004R0853R(10)
This corrigendum does not concern the English version.
-
62010TA0526
Case T-526/10: Judgment of the General Court of 25 April 2013 — Inuit Tapiriit Kanatamiand Others v Commission (Trade in seal products — Regulation (EC) No 1007/2009 — Detailed rules for implementation — Regulation (EU) No 737/2010 — Prohibition on placing such products on the market — Exception in favour of Inuit communities — Plea of illegality — Legal basis — Subsidiarity — Proportionality — Misuse of powers)
OJ C 164, 8.6.2013, p. 14–15 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
-
32013R0500
Commission Regulation (EU) No 500/2013 of 30 May 2013 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, Adoxophyes orana granulovirus strain BV-0001, azoxystrobin, clothianidin, fenpyrazamine, heptamaloxyloglucan, metrafenone, Paecilomyces lilacinus strain 251, propiconazole, quizalofop-P, spiromesifen, tebuconazole, thiamethoxam and zucchini yellow mosaik virus - weak strain in or on certain products Text with EEA relevance
OJ L 151, 4.6.2013, p. 1–32 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
